Obesity at parity with the state, a Medicaid agency headquartered in town that excludes weight-loss GLP-1s in writing, and zero published cash prices in the city.
Charleston's paradox is not its obesity number. At 40.2% of adults (CDC PLACES, BRFSS 2023) 1, the city sits essentially at parity with West Virginia's 41.2% 2, a hair below rather than above. Kanawha County's seat holds 47,421 residents in a 200,122-person metro, with a 4.0% uninsured rate and a $65,812 median household income 34.
The agency that writes West Virginia Medicaid's drug rules, the Bureau for Medical Services, is headquartered in Charleston at 350 Capitol Street, and its own current criteria exclude GLP-1s used for weight loss. Meanwhile the city holds the state's densest medical-weight-loss infrastructure and publishes no GLP-1 price anywhere in it 789.
West Virginia Medicaid's Bureau for Medical Services treats GLP-1s for plain weight loss as excluded, in writing, in both of its current prior-authorization criteria documents. The Wegovy (semaglutide) criteria, effective 1/1/2026, state: "Agents used for the purpose of weight loss are typically a benefit exclusion. Coverage of Wegovy will only be considered for the secondary prevention of a cardiovascular event and/or a diagnosis of MASH." That pathway requires BMI at or above 27 plus a prior MI, stroke or symptomatic PAD, or a biopsy or elastography-confirmed MASH diagnosis with stage 2 to 3 fibrosis, and explicitly excludes anyone with type 1 or type 2 diabetes or an HbA1c above 6.5% 7.
The Zepbound (tirzepatide) criteria, effective 7/1/2025, state: "Agents used for the purpose of weight loss are typically a benefit exclusion and not covered by West Virginia Medicaid. Coverage of Zepbound will only be considered for a diagnosis of OSA in adults with obesity," requiring BMI at or above 30 plus a sleep study showing AHI at or above 15 per hour within the past year 8. No WV Medicaid pathway exists for GLP-1 coverage on an obesity diagnosis alone: only as downstream treatment for a cardiovascular event, liver disease, or sleep apnea.
The local price table is empty, and the absence is the finding. CAMC / Vandalia Health's Weight Loss Center, self-described as "the only MBSAQIP Accredited Comprehensive Center in Charleston," runs bariatric surgery (sleeve, bypass, duodenal switch, ESG, Orbera, SADI-S, revisional and robotic options) plus a medical weight loss program from Charleston and Teays Valley. Confirmed by direct fetch, its service page publishes no self-pay or cash price for semaglutide, tirzepatide or any GLP-1 medication; the only contact given is a phone number, 304-388-4965, for seminar information 9.
WVU Medicine's Thomas Memorial Hospital in South Charleston, the metro's second hospital system, shows no weight-loss, bariatric or GLP-1 program in the service navigation checked 10. National franchises come up empty in the state: Medi-Weightloss's own 140-location directory lists zero West Virginia locations 11, and Sono Bello's directory lists zero as well, though its national service menu references "Post GLP-1 Weight Loss Support" with no city tie and no price 12. BBB's Charleston business-category index carries no weight-loss, medical-spa, wellness-center or dietitian category at all, and a BBB search for medical weight loss near Charleston returned zero businesses in the city or state, with the nearest 30 results 100-plus miles away in Ohio, Virginia or Kentucky 13. Ideal Image's site returned an under-construction placeholder, so its West Virginia footprint is unconfirmed either way rather than zero, and this sweep rests on directory and direct-fetch checks rather than a full open-web search.
Astra's national price is the same string used on every other city page: $68/mo for semaglutide and $118/mo for tirzepatide on 12-month plans ($816 / $1,416 billed annually). In a city where the hospital system requires a phone call and a seminar to learn what treatment costs, it is the only number a Charleston patient can see before starting.
Specialist supply is comparatively strong for the state. CAMC / Vandalia Health's own provider directory reportedly lists 8 adult and 2 pediatric CAMC Endocrinology providers, plus an independent practice, Charleston Endocrinology Associates, and a dedicated Vandalia Health Weight Loss Center with 12 providers in Charleston and 2 more at a Teays Valley satellite about 17 miles west, covering bariatric surgery and medical weight management 9. Two caveats travel with that: HRSA does not track obesity medicine or endocrinology as HPSA disciplines, so there is no federal shortage benchmark to measure it against, and these are self-reported directory counts that were not independently re-verified or deduplicated.
Kanawha County does carry four active HRSA shortage designations, none of them citywide (national HPSA bulk files, pulled Aug 28 2026). Primary Care: Cabin Creek Health Systems, Inc., an FQHC Charleston site, score 20, designated 2002, plus the "LI-Kanawha County" low-income population, score 17, designated 2016, population 60,086, 16.1% below poverty, population-to-provider ratio 5,093:1. Mental Health: the same FQHC at score 21 and the same low-income population at score 18, designated 2017, with a formal ratio of 218,495:1. Dental Health: the same FQHC at score 23 and the same low-income population at score 17 6. Every active designation is population-based or facility-based, so the gap is access for the poor and uninsured, not the general population.
Telehealth removes the specific friction Charleston's market imposes: no seminar to attend, no referral line to call, no consultation required before a price is disclosed.
Astra treats patients in West Virginia through state-licensed physicians.
No. West Virginia Medicaid's Bureau for Medical Services, headquartered in Charleston, explicitly excludes GLP-1 drugs used "for the purpose of weight loss" from coverage. Its Wegovy prior-authorization criteria (effective 1/1/2026) allow coverage only after a prior heart attack, stroke, symptomatic PAD, or a confirmed MASH liver diagnosis — never for obesity alone. Zepbound (effective 7/1/2025) is covered only for moderate-to-severe obstructive sleep apnea with obesity. There is no Medicaid pathway for GLP-1 coverage based on an obesity diagnosis by itself.
Charleston's largest GLP-1 provider, CAMC/Vandalia Health's Weight Loss Center — the only MBSAQIP-accredited comprehensive bariatric center in the city — does not publish a self-pay price for semaglutide, tirzepatide, or any GLP-1 medication on its website; the only listed contact is a phone number for seminar information. WVU Medicine's Thomas Memorial Hospital lists no weight-loss or GLP-1 program at all. National franchises Medi-Weightloss and Sono Bello both show zero West Virginia locations in their own directories. As of August 2026, no clinic checked in Charleston publishes a GLP-1 cash price.
Kanawha County carries four active federal Health Professional Shortage Area designations from HRSA — in primary care, mental health, and dental health — all tied to the county's low-income population (16.1% poverty rate) and its single safety-net FQHC, Cabin Creek Health Systems. The mental-health shortage is especially severe, with a formal population-to-provider ratio of 218,495:1. These are population- and facility-based designations, not a shortage across the whole city — Charleston itself is not classified as a geographic shortage area.
40.2% of Charleston adults have obesity (CDC PLACES, 2023 BRFSS data), just below West Virginia's statewide rate of 41.2% — essentially at parity. Unlike many mid-sized cities, Charleston isn't a local outlier; its obesity burden matches the state's, which is itself among the highest in the country.
Astra's price is the same everywhere Astra serves — $68/month for semaglutide and $118/month for tirzepatide on 12-month plans ($816/$1,416 billed annually) — and there's no local clinic price in Charleston to compare it against, since none checked publishes one. Where Charleston's own hospital system requires a phone call and a seminar just to learn what treatment costs, Astra's price is public and fixed before you start.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.